[1]
M. Basim Najm, S. D. . Jalal, and H. A. . Getta, “The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience: JAK2 V617F, CALR and MPL mutations as molecular diagnostic markers”, Cell Mol Biol (Noisy-le-grand), vol. 68, no. 8, Aug. 2022.